Role of the manganese efflux system mntE for signalling and pathogenesis in Streptococcus pneumoniae

Jason W Rosch1, Geli Gao, Granger Ridout

  • 1Department of Infectious Diseases, St Jude's Children's Research Hospital, Memphis, TN 38105, USA. Jason.Rosch@stjude.org

Molecular Microbiology
|February 20, 2009
PubMed

Insights

Streptococcus pneumoniae uses a novel manganese efflux system (mntE) to maintain virulence. Disrupting this system increases manganese sensitivity and reduces disease severity, suggesting it as a potential antimicrobial target.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pathogenesis

Background:

  • Bacterial metal ion homeostasis is crucial for pathogenesis.
  • Manganese acquisition is vital for bacterial virulence.
  • Manganese efflux systems in bacteria remain largely uncharacterized.

Purpose of the Study:

  • To identify and characterize a manganese efflux system in Streptococcus pneumoniae.
  • To investigate the role of manganese export in bacterial virulence and host-pathogen interactions.

Main Methods:

  • Identification of a cation diffusion facilitator (CDF) protein (Sp1552) functioning in manganese export.
  • Gene designation as mntE and creation of a mutant strain.
  • Assessment of manganese sensitivity, oxidative stress resistance, and virulence in a murine infection model.

Main Results:

  • The mntE mutant exhibited high sensitivity to manganese stress.
  • The mutant showed increased resistance to oxidative stress and enhanced production of H(2)O(2) and pili.
  • Reduced virulence of the mntE mutant in a murine model of infection was observed, indicating manganese export's role in pathogenesis.
  • Differential transcriptional responses to extracellular and intracellular manganese accumulation were noted.

Conclusions:

  • Manganese efflux via mntE is essential for Streptococcus pneumoniae virulence and invasive disease.
  • The identified manganese export system represents a potential novel antimicrobial target for therapeutic development.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...